Select Better Antibodies Using NGS Data
Antibody development holds the key to many effective drugs. However, the process of selecting the best candidates remains limited by the screening capabilities and investment costs of next-generation sequencing (NGS) techniques.
This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection..
Download this whitepaper to discover:
- An accelerated discovery workflow that explores multiple characteristics from sequence, assay, and in silico predicted data
- How to de-risk antibody development by annotating structural liabilities
- How to easily perform hit expansion, selection and enrichment analyses